Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Letter
  • Published:

Elevated systolic blood pressure is present in almost all individuals with newly diagnosed diabetes

Journal of Human Hypertension volume 20, pages 231–233 (2006)Cite this article

The prevalence of hypertension in type 2 diabetes patients is substantially greater than in nondiabetes population and is reported between 40 and 60%.1 In the United Kingdom Prospective Diabetes Study (UKPDS) 40% of men and 53% of women were found to have BP over 160/95 mmHg.2 Coexistence of diabetes and hypertension is particularly unfavourable as both conditions are significant risk factors for vascular injury.1

In 2003 Joint National Committee Seventh report (JNC 7) set a threshold for normal BP <120/80 mmHg and introduced new category of prehypertension (i.e. systolic blood pressure (SBP) 120–139 or diastolic blood pressure (DBP) 80–89 mmHg). According to this report hypertension should be diagnosed if SBP is greater or equal to 140 mmHg and DBP to 90 mmHg.1 We performed a study aiming at assessing BP in newly diagnosed diabetes mellitus patients, in whom hypertension had never been diagnosed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chobanian AV, Bakris GL, Black HB, Cushman WC, Green LA, Izzo JL et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.

    Article  CAS  Google Scholar 

  2. United Kingdom prospective diabetes study. III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes. A multicenter study. Hypertension 1985; 7 (Suppl II): II-8–II-13.

  3. Drzewoski J, Saryusz-Wolska M, Czupryniak L . Prevalence of type 2 diabetes mellitus and selected metabolic disorders in urban population aged &gt;35 years. Pol Arch Med Wewn 2001; 106: 787–791.

    CAS  PubMed  Google Scholar 

  4. Williams B, Poulter NR, Brown MJ, Davis M, McInnes G, Potter JF, et al., the BHS guidelines working party, for the British Hypertension Society. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–640.

    Article  Google Scholar 

  5. Colagiuri S, Borch-Johnsen K, Glumer C, Vistisen D . There really is an epidemic of type 2 diabetes. Diabetologia 2005; 48: 1459–1463.

    Article  CAS  Google Scholar 

  6. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P . The Burden of Adult Hypertension in the United States 1999 to 2000. A rising tide. Hypertension 2004; 44: 398–404.

    Article  CAS  Google Scholar 

  7. Cushman W . Systolic hypertension and cardiovascular risk reduction: a clinical review. Curr Hypertension Rep 2001; 3 (Suppl 1): S11–S15.

    Article  Google Scholar 

  8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

  9. Vlassara H, Palace MR . Diabetes and advanced glycation endproducts. J Intern Med 2002; 251: 87–101.

    Article  CAS  Google Scholar 

  10. Kramer H . Screening for kidney disease in adults with diabetes and prediabetes. Curr Opin Nephrol Hypertens 2005; 14: 249–252.

    Article  Google Scholar 

  11. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383–393.

    Article  Google Scholar 

  12. Appel LJ, Champagne CM, Harsh DW, Cooper LS, Obarzanek LE, Elmer PJ et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. Writing Group of the PREMIER Collaborative Research Group. JAMA 2003; 289: 2083–2093.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diabetology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland

    L Czupryniak, M Saryusz-Wolska, M Pawlowski & J Loba

Authors
  1. L Czupryniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Saryusz-Wolska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Pawlowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Loba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L Czupryniak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Czupryniak, L., Saryusz-Wolska, M., Pawlowski, M. et al. Elevated systolic blood pressure is present in almost all individuals with newly diagnosed diabetes. J Hum Hypertens 20, 231–233 (2006). https://doi.org/10.1038/sj.jhh.1001962

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001962

This article is cited by

Search

Advanced search

Quick links